A New Optical and Nuclear Dual-Labeled Imaging Agent Targeting Interleukin 11 Receptor Alpha-Chain
详细信息    查看全文
文摘
Optical imaging has great potential for studying molecular recognitions both in vivo and in vitro, yet nuclearimaging is the most effective clinical molecular imaging modality. The combination of optical and nuclear imagingmodalities may provide complementary information for improving diagnosis and management of diseases. In thisstudy we developed an optical and nuclear dual-labeled imaging agent, 111In-DTPA-Bz-NH-SA-K(IR-783-S-Ph-CO)-c(CGRRAGGSC)NH2, called DLIA-IL11R. 111In-DTPA-Bz-NH-SA is the radiotracer moiety; a near-infrareddye IR-783-S-Ph-COOH serves as the fluorescent emitter; and the cyclic peptide c(CGRRAGGSC), which isknown to target interleukin 11 receptor alpha-chain (IL-11R), delivers the desired imaging agent to its target.Experiments revealed that the cyclic peptide c(CGRRAGGSC) continued to possess the targeting capability toIL-11R after the conjugation of the optical and nuclear tracers. Furthermore, the presence of the metal isotopechelator did not cause quenching of fluorescence emission. The cross validation and direct comparison of opticaland nuclear imaging of a tumor was achieved using a single injection, and the preliminary results show theconjugate has tumor targeting capabilities in vivo.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700